Providence Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.94M | Buy |
65,100
+8,700
| +15% | +$794K | 1.09% | 41 |
|
|
2025
Q1 | $6.38M | Buy |
56,400
+800
| +1% | +$90.5K | 1.33% | 22 |
|
|
2024
Q4 | $5.87M | Buy |
55,600
+2,800
| +5% | +$296K | 1.19% | 37 |
|
|
2024
Q3 | $5.7M | Buy |
52,800
+4,191
| +9% | +$452K | 1.13% | 42 |
|
|
2024
Q2 | $5.28M | Buy |
48,609
+48,600
| +540,000% | +$5.27M | 1.15% | 40 |
|
|
2024
Q1 | $1.19K | Buy |
+9
| New | +$1.19K | ﹤0.01% | 311 |
|
|
2019
Q2 | – | Sell |
-41
| Closed | -$5K | – | 312 |
|
|
2019
Q1 | $5K | Hold |
41
| – | – | ﹤0.01% | 218 |
|
|
2018
Q4 | $4K | Hold |
41
| – | – | ﹤0.01% | 229 |
|
|
2018
Q3 | $5K | Hold |
41
| – | – | ﹤0.01% | 234 |
|
|
2018
Q2 | $4K | Hold |
41
| – | – | ﹤0.01% | 235 |
|
|
2018
Q1 | $4K | Hold |
41
| – | – | ﹤0.01% | 234 |
|
|
2017
Q4 | $5K | Buy |
+41
| New | +$5K | ﹤0.01% | 268 |
|